Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transarterial embolization with sorafenib in animal livers: a pharmacokinetics study.
Chatziioannou AN, Siskos AP, Loxas D, Kavatzas N, Agrogiannis G, Fokas D, Malagari K, Kostomitsopoulos NG, Tsigkou O, Tamvakopoulos C. Chatziioannou AN, et al. Among authors: tamvakopoulos c. J Vasc Interv Radiol. 2013 Nov;24(11):1657-63.e1. doi: 10.1016/j.jvir.2013.08.007. Epub 2013 Sep 21. J Vasc Interv Radiol. 2013. PMID: 24060438
Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.
Malagari K, Pomoni M, Moschouris H, Kelekis A, Charokopakis A, Bouma E, Spyridopoulos T, Chatziioannou A, Sotirchos V, Karampelas T, Tamvakopoulos C, Filippiadis D, Karagiannis E, Marinis A, Koskinas J, Kelekis DA. Malagari K, et al. Among authors: tamvakopoulos c. Cardiovasc Intervent Radiol. 2014 Feb;37(1):165-75. doi: 10.1007/s00270-013-0777-x. Epub 2013 Nov 22. Cardiovasc Intervent Radiol. 2014. PMID: 24263774 Free PMC article.
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug delivery.
Karampelas T, Argyros O, Sayyad N, Spyridaki K, Pappas C, Morgan K, Kolios G, Millar RP, Liapakis G, Tzakos AG, Fokas D, Tamvakopoulos C. Karampelas T, et al. Among authors: tamvakopoulos c. Bioconjug Chem. 2014 Apr 16;25(4):813-23. doi: 10.1021/bc500081g. Epub 2014 Apr 3. Bioconjug Chem. 2014. PMID: 24661240
Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα Enzyme.
Daniilides K, Lougiakis N, Evangelidis T, Kostakis IK, Pouli N, Marakos P, Mikros E, Skaltsounis AL, Bach S, Baratte B, Ruchaud S, Karamani V, Papafotika A, Christoforidis S, Argyros O, Kouvari E, Tamvakopoulos C. Daniilides K, et al. Among authors: tamvakopoulos c. Anticancer Agents Med Chem. 2017;17(7):990-1002. doi: 10.2174/1871520616666161207143450. Anticancer Agents Med Chem. 2017. PMID: 27928955
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.
Spathis AD, Asvos X, Ziavra D, Karampelas T, Topouzis S, Cournia Z, Qing X, Alexakos P, Smits LM, Dalla C, Rideout HJ, Schwamborn JC, Tamvakopoulos C, Fokas D, Vassilatis DK. Spathis AD, et al. Among authors: tamvakopoulos c. Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3999-4004. doi: 10.1073/pnas.1616874114. Epub 2017 Mar 27. Proc Natl Acad Sci U S A. 2017. PMID: 28348207 Free PMC article.
Versatile quarto stimuli nanostructure based on Trojan Horse approach for cancer therapy: Synthesis, characterization, in vitro and in vivo studies.
Efthimiadou EK, Fragogeorgi E, Palamaris L, Karampelas T, Lelovas P, Loudos G, Tamvakopoulos C, Kostomitsopoulos N, Kordas G. Efthimiadou EK, et al. Among authors: tamvakopoulos c. Mater Sci Eng C Mater Biol Appl. 2017 Oct 1;79:605-612. doi: 10.1016/j.msec.2017.05.082. Epub 2017 May 13. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28629059
68 results